Second death in Novartis gene therapy trials under investigation

20 april 2019 | Bron: Reuters Health

Novartis AG, which this week announced positive interim trial results for its experimental gene therapy for spinal muscular atrophy, on Friday said investigation is underway into whether a second trial death could be related to the treatment.

Lees verder op: Reuters Health